- likes
- 64
- comments
- 1
Post
There is still much to understand about systemic lupus erythematosus (SLE) and the immune processes involved in this disease. At #ACR2026, we are presenting two analyses from the placebo-controlled Phase 2 trial for an investigational asset as part of our commitment to deepening scientific understanding of SLE. 👉 Explore abstracts 0259 and 0285: Nov. 8 | 10:30 a.m.-12:30 p.m. ET | Location: WB1&2 https://cdmcd.co/xK9vrZ https://cdmcd.co/YK6q7R